688166.SS
688166.SS
CNE100003PR1
BRIGHTGENE BIO-MEDICAL TECHNOLO
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.223.640.130 1.282.551.615
4.6%
Cost of Revenue 601.611.553 544.950.816
10.4%
Gross Profit 622.028.577 737.600.799
15.7%
511.830.473 486.773.378
5.1%
Operating Income 110.198.103 250.827.421
56.1%
Pretax Income 13.908.831 157.200.608
91.2%
Net Income Common Stockholders 54.514.681 189.166.937
71.2%
-- --
--
-- --
--
ende